Coumaphos (Co-Ral)

Coumaphos, marketed primarily under the brand name Co-Ral, represents one of the most established organophosphate insecticides used in livestock production for controlling external parasites. This compound has been a mainstay in cattle ectoparasite management programs since its introduction and continues to serve as an effective tool against a broad spectrum of arthropod pests that affect cattle health and productivity. As an organophosphate, coumaphos works by inhibiting the enzyme acetylcholinesterase, which is essential for normal nerve function in insects and arachnids, leading to their rapid elimination from treated animals.

The mechanism of action of coumaphos involves irreversible binding to acetylcholinesterase enzymes in target parasites. When external parasites such as lice, grubs, flies, or ticks come into contact with or ingest coumaphos, the compound prevents the breakdown of acetylcholine at nerve synapses. This results in continuous nerve stimulation, leading to paralysis and death of the parasite. The compound demonstrates both contact and systemic activity depending on the formulation and application method, providing comprehensive protection against various life stages of target pests.

Coumaphos is available in multiple formulations designed to accommodate different treatment scenarios and producer preferences. Spray concentrates allow for whole-body treatment of cattle using standard spray equipment, while dust formulations provide convenient self-treatment options when used in dust bags or applied directly. Pour-on formulations offer ease of application for individual animal treatment, and dip concentrates remain available for intensive treatment of heavily infested herds or for treating cattle prior to movement. Each formulation is engineered to deliver effective concentrations of the active ingredient while ensuring practical application under farm conditions.

From a regulatory standpoint, coumaphos holds approval for use on cattle in the United States and many other countries, though specific formulations may carry restricted use pesticide designations requiring certified applicator status for purchase and application. The compound has a long history of effective use when applied according to label directions, though producers must adhere strictly to withdrawal periods and application restrictions to ensure food safety and prevent residue violations. Understanding the regulatory requirements and safety considerations associated with organophosphate products is essential for responsible use of coumaphos in modern livestock operations.

The primary indication for coumaphos in cattle is the control of cattle grubs, specifically the larvae of Hypoderma bovis and Hypoderma lineatum, which cause significant economic losses in beef and dairy operations. Cattle grub infestations result in hide damage, reduced weight gains, decreased milk production, and carcass trim losses at slaughter. Coumaphos systemic pour-on formulations are particularly effective when applied during the grub migration period, killing larvae before they cause damage to the hide and back muscles. Treatment timing is critical, with applications typically recommended in late fall or early winter in northern regions to target grubs before they reach the esophageal or spinal areas.

Lice infestations represent another major indication for coumaphos treatment in cattle operations. Both sucking lice species such as Linognathus vituli, Haematopinus eurysternus, and Solenopotes capillatus, and biting lice including Bovicola bovis respond well to coumaphos treatment. Lice populations build during winter months when cattle are confined and coat conditions favor louse reproduction, making winter and early spring treatment particularly important. Spray and dust formulations provide effective contact activity against lice on treated cattle, while pour-on formulations offer systemic activity that can extend the duration of protection.

Horn flies and face flies cause substantial irritation and production losses in pastured cattle during warm months, and coumaphos dust formulations in self-treatment devices such as dust bags and oilers provide ongoing control when properly positioned in areas cattle frequent daily. The residual activity of coumaphos on the hair coat provides extended protection between applications, reducing fly populations and the associated stress and blood loss that impair cattle performance. Backrubbers and face flips charged with oil-based coumaphos formulations offer alternative delivery methods for fly control in extensive grazing operations.

Tick control represents an important use of coumaphos, particularly in regions where tick-borne diseases such as anaplasmosis and babesiosis pose threats to cattle health. Gulf coast ticks, lone star ticks, and other species can be effectively controlled with spray or dip applications of coumaphos, reducing disease transmission risk and preventing the irritation and blood loss associated with heavy tick burdens. In tick eradication programs, coumaphos dips have historically played a central role in systematic treatment protocols designed to eliminate fever tick populations from cattle and premises.

Beyond the primary labeled indications, coumaphos demonstrates activity against mange mites in cattle, including Sarcoptes scabiei and Psoroptes ovis, which cause significant skin damage and production losses. Mange treatment typically requires multiple applications at specified intervals to eliminate mites through successive generations, with spray applications providing thorough coverage of affected skin areas. Producers should consult with veterinarians regarding specific treatment protocols for mange infestations, as these conditions often require integrated management approaches combining treatment with environmental control measures.

Dosage and administration protocols for coumaphos vary significantly based on the formulation being used and the target parasites being controlled. Pour-on formulations for cattle grub control are typically applied at a rate of 4 milligrams of coumaphos per kilogram of body weight, delivered along the backline from the withers to the tailhead. This translates to approximately 0.5 fluid ounces of a standard 4% pour-on formulation per 100 pounds of body weight. Accurate weight estimation is essential to ensure adequate dosing while avoiding excessive application that could contribute to residue concerns or increase the risk of adverse effects.

Spray applications require preparation of appropriate dilutions according to label directions, with concentrations typically ranging from 0.25% to 0.5% coumaphos for lice and tick control. High-pressure sprays should deliver approximately one to two quarts of prepared solution per adult animal, ensuring complete coverage of the entire body surface including the head, ears, underline, and legs. Low-pressure sprays may require higher volumes to achieve adequate coverage. Retreatment intervals typically range from two to three weeks depending on the target parasite and severity of infestation, with specific guidance provided on product labels.

Dip applications represent the most intensive treatment method and are typically reserved for tick control programs or severe parasite infestations requiring comprehensive treatment of all animals. Dip concentrations are carefully specified on product labels, typically ranging from 0.25% to 0.5% active ingredient, and must be maintained through regular testing and replenishment to ensure consistent efficacy. Animals should remain in the dip for sufficient time to ensure complete wetting, typically 30 seconds to one minute, with particular attention to submerging the head and ears where ticks commonly attach.

Dust formulations for self-treatment applications in bags or oilers require placement in areas where cattle will contact the devices at least once daily, such as in lanes leading to water sources or mineral feeders. Dust bags should be positioned at appropriate heights to contact the face, neck, and back of cattle as they pass beneath. The dust concentration and bag design ensure that cattle receive adequate amounts of coumaphos during each contact. Regular refilling of dust bags and maintenance of oilers ensures continuous availability of the insecticide throughout fly seasons.

Withdrawal times for coumaphos are critical considerations that must be strictly observed to prevent violative residues in meat and milk. For beef cattle treated with pour-on formulations for grub control, a withdrawal period of at least 14 days before slaughter is typically required, though this may vary by specific product. Lactating dairy cattle have specific restrictions, with some formulations prohibited in dairy animals of breeding age and others requiring extended withdrawal periods for milk. Producers must carefully review product labels for the specific formulation being used and maintain treatment records documenting application dates, products used, and individual animal identification.

Proper application technique is essential for both efficacy and safety when using coumaphos products. Animals should be appropriately restrained to allow thorough application while minimizing handler exposure. Pour-on products should be applied to dry hair along the backline, avoiding application during rain or when cattle are wet. Spray applications should be conducted in well-ventilated areas with appropriate personal protective equipment, and operators should position themselves to minimize exposure to spray drift. Following application, treated animals should be observed for signs of toxicity, particularly when treating debilitated animals or during hot weather conditions.

Coumaphos demonstrates a generally acceptable safety profile in cattle when applied according to label directions, though as an organophosphate compound, it carries inherent risks that producers and veterinarians must understand. The therapeutic index for cattle is reasonably wide under normal conditions, but factors such as animal stress, concurrent illness, high environmental temperatures, or improper dosing can narrow this margin and increase the likelihood of adverse effects. Understanding the signs of organophosphate toxicity is essential for all individuals involved in applying or managing cattle treated with coumaphos.

Common side effects following coumaphos application in cattle are generally mild and transient. Some animals may exhibit temporary restlessness, increased salivation, or mild gastrointestinal disturbance following treatment. These effects typically resolve within hours without intervention and do not require specific treatment. Local reactions at application sites, particularly with pour-on formulations, may include temporary hair coat changes or mild skin irritation, though significant local reactions are uncommon with properly applied products. Cattle may show behavioral changes such as increased activity or temporary reduction in feed intake immediately following treatment.

Injection site reactions are not applicable to coumaphos as it is administered topically rather than by injection, but skin reactions following dip or spray applications may occasionally occur. Animals with pre-existing skin conditions or those with compromised skin integrity may be more susceptible to local irritation. Hypersensitivity reactions, while rare, have been reported and may manifest as localized swelling, hair loss, or more generalized skin reactions. Animals showing hypersensitivity should not be retreated with coumaphos or related organophosphate compounds.

Serious adverse effects from coumaphos represent manifestations of organophosphate toxicity related to cholinesterase inhibition. Signs of toxicity include profuse salivation, lacrimation, urination, and defecation, often remembered by the acronym SLUD. More advanced toxicity produces muscle fasciculations, weakness, incoordination, difficulty breathing due to bronchospasm and increased respiratory secretions, and potentially death from respiratory failure. These effects result from acetylcholine accumulation at muscarinic and nicotinic receptors throughout the body. Treatment of organophosphate toxicity requires immediate veterinary intervention with atropine sulfate to block muscarinic effects, and pralidoxime may be indicated if administered early after exposure.

Species-specific toxicity considerations are particularly important when cattle operations also maintain other livestock species. Horses are considerably more sensitive to organophosphate compounds than cattle and should never be treated with coumaphos products labeled for cattle. Young calves may be more susceptible to toxicity than adult cattle, and conservative dosing approaches should be employed when treating animals under three months of age. Brahman and Brahman-cross cattle have demonstrated increased sensitivity to organophosphate compounds in some reports, and additional caution may be warranted when treating these breeds. Stressed, debilitated, or febrile animals should not be treated with coumaphos, as their reduced ability to metabolize and eliminate the compound increases toxicity risk.

Coumaphos is contraindicated in several species due to heightened sensitivity to organophosphate compounds that creates unacceptable toxicity risks. Horses must never be treated with coumaphos or any other organophosphate products labeled for cattle use, as equines demonstrate marked sensitivity that can result in severe toxicity or death even at doses well tolerated by cattle. This species restriction is absolute and applies to all coumaphos formulations regardless of concentration or application method. Similarly, coumaphos should not be used on suckling pigs, poultry, or companion animals such as dogs and cats.

Restrictions based on production stage represent important contraindications that protect food safety and prevent residue violations. Many coumaphos formulations are contraindicated in lactating dairy cattle, and those formulations that can be used carry specific milk withdrawal requirements that must be strictly observed. Producers of milk for human consumption must verify that any coumaphos product they consider using is approved for dairy cattle and must document compliance with withdrawal periods. Dairy animals within the withdrawal period should be milked separately with milk discarded, and systems must be in place to prevent co-mingling of withheld milk with saleable product.

Age and weight restrictions apply to coumaphos use in cattle, with most products specifying minimum ages or weights below which treatment is not recommended. Calves under three months of age or weighing less than specified minimum weights may be more susceptible to toxicity due to immature metabolic systems. Very young calves receiving milk from treated dams should be monitored, as organophosphate compounds can be excreted in milk at levels that may affect nursing animals. The product label provides specific guidance on age and weight restrictions that must be followed.

Disease state contraindications are critical considerations when planning coumaphos treatments. Sick, debilitated, or stressed cattle should not be treated with organophosphate products due to reduced ability to metabolize and detoxify these compounds. Cattle experiencing severe parasitism with anemia, cattle recovering from recent illness, or cattle stressed by transportation, handling, or adverse environmental conditions should have treatment delayed until they have recovered. Animals previously showing sensitivity or adverse reactions to organophosphate compounds should not be retreated with coumaphos. The timing restriction for treating cattle with grubs in the esophageal or spinal area is particularly important, as killing larvae in these locations can cause severe reactions including bloat from esophageal swelling or posterior paralysis from spinal inflammation.

Drug interactions involving coumaphos primarily relate to its mechanism as a cholinesterase inhibitor and the potential for additive or synergistic effects with other compounds affecting cholinergic systems. The most significant interactions involve other organophosphate or carbamate compounds, which also inhibit cholinesterase enzymes through similar mechanisms. Concurrent or recent use of organophosphate dewormers, other organophosphate ectoparasiticides, or organophosphate-containing premises sprays can result in cumulative cholinesterase inhibition that exceeds the threshold for clinical toxicity. A minimum interval of 10 to 14 days should elapse between applications of different organophosphate products.

Carbamate compounds, including carbamate insecticides and the carbamate anthelmintic levamisole, also inhibit cholinesterase and may interact with coumaphos. While carbamate inhibition is typically reversible compared to the irreversible inhibition caused by organophosphates, concurrent exposure can still produce additive effects. Levamisole treatment should be separated from coumaphos application by appropriate intervals, and premises should not be treated with carbamate insecticides immediately before or after cattle receive coumaphos treatments.

Phenothiazine tranquilizers and certain other sedative compounds may potentiate the effects of organophosphate compounds and should be used with caution in recently treated animals. Acepromazine and related phenothiazine derivatives can lower seizure thresholds and may increase the risk of central nervous system effects in animals with reduced cholinesterase activity following organophosphate exposure. If sedation or anesthesia is required in cattle recently treated with coumaphos, veterinarians should consider alternative agents and use conservative dosing.

Feed additives commonly used in cattle production can potentially interact with organophosphate ectoparasiticides. Ionophore antibiotics such as monensin, lasalocid, and salinomycin, while not directly interacting with coumaphos pharmacologically, may affect animal metabolism and stress responses in ways that alter susceptibility to organophosphate toxicity. Cattle experiencing ionophore toxicity or cattle recently started on ionophore-containing feeds may be more vulnerable to adverse effects from ectoparasiticide treatment. Vaccine administration should ideally be separated from coumaphos treatment to avoid confounding the interpretation of any adverse reactions that might occur and to minimize overall stress on the animal's immune and metabolic systems.

Human safety precautions are paramount when handling and applying coumaphos products, as this organophosphate compound readily absorbs through human skin, lungs, and mucous membranes. All handlers must wear appropriate personal protective equipment including chemical-resistant gloves, long-sleeved shirts, long pants, and eye protection. When applying sprays or working with dips, respiratory protection may be indicated, particularly in enclosed or poorly ventilated areas. Workers should wash thoroughly with soap and water after handling coumaphos products and before eating, drinking, or using tobacco products. Contaminated clothing should be laundered separately from other household items.

Food safety and residue avoidance represent critical aspects of responsible coumaphos use in food-producing animals. Producers must understand and strictly observe all withdrawal periods specified on product labels, as organophosphate residues in meat or milk pose public health concerns. Treated animals must be identified and tracked to prevent inadvertent sale or slaughter before withdrawal periods expire. Milk from treated dairy cattle must be withheld from sale for the specified period, and proper disposal of withheld milk must be ensured. Treatment records should document the product used, date of application, animal identification, and calculated slaughter or milk withhold dates.

Environmental considerations include proper disposal of empty containers, unused product, and treatment solutions such as spent dip. Coumaphos is toxic to fish, aquatic invertebrates, and honeybees, and contamination of waterways must be prevented. Triple-rinsing containers before disposal, proper containment of dip solutions, and prevention of runoff from treatment areas are essential practices. Premises sprays containing coumaphos should be applied carefully to avoid contamination of feed, water sources, and areas accessible to non-target animals.

Resistance concerns have emerged in some parasite populations following decades of organophosphate use, and judicious application practices help preserve the utility of this compound class. Rotation with products having different mechanisms of action, appropriate treatment intervals, and confirming treatment need before applying products all contribute to resistance management. Cattle lice populations in particular have demonstrated resistance to organophosphates in some regions, and monitoring treatment efficacy through post-treatment evaluation helps identify potential resistance early.

Proper use practices maximize efficacy while minimizing risks associated with coumaphos application. Treatment should occur during cooler parts of the day in summer months, as heat stress combined with organophosphate exposure increases toxicity risk. Animals should be handled calmly to minimize stress-related susceptibility. Pour-on products should be applied to dry coats for optimal absorption and distribution. Following treatment, cattle should be observed for two to four hours for signs of adverse reactions, with particular attention during the period of peak absorption. Access to atropine sulfate for emergency treatment of toxicity is advisable on operations routinely using organophosphate products.

Storage requirements for coumaphos products emphasize protection from environmental conditions that could degrade the active ingredient or compromise container integrity. Products should be stored in original containers in a cool, dry, well-ventilated area away from direct sunlight. Temperature extremes should be avoided, as prolonged exposure to freezing or high heat can affect product stability and efficacy. Storage areas should be secured to prevent access by children, unauthorized persons, and animals. Coumaphos products should be stored separately from feed, seed, fertilizer, and other agricultural products to prevent cross-contamination.

Multi-dose container handling requires attention to practices that maintain product integrity throughout use. Liquid concentrates should be examined before use for signs of precipitation, separation, or crystallization that might indicate product degradation. Containers should be tightly closed after each use to prevent evaporation of solvents and concentration of active ingredients. Measuring and transfer equipment should be dedicated to pesticide use and not used for other purposes. Spills should be cleaned immediately using absorbent material, with contaminated materials disposed of according to label directions.

Disposal of coumaphos products and containers must follow label directions and applicable regulations to prevent environmental contamination and human exposure. Empty containers should be triple-rinsed, with rinsate added to the spray tank or disposed of according to label directions. Rinsed containers may be recycled where programs exist or disposed of in approved landfills. Unused product should never be poured down drains, into waterways, or onto the ground. Spent dip solutions require proper disposal according to local regulations, which may involve treatment, permitted land application, or collection by licensed waste handlers. Consultation with state environmental agencies may be necessary to determine appropriate disposal methods for large volumes of waste solution.

Species-specific dosing considerations are essential when applying coumaphos to cattle versus the other livestock species for which some formulations may be labeled. Cattle generally tolerate coumaphos well at labeled doses, but individual variation exists, and conservative approaches should be employed when treating mixed groups including lightweight or debilitated animals. Swine formulations, where available, use different concentrations appropriate for that species, and cattle products should never be substituted for species-appropriate formulations.

Breed sensitivities to organophosphate compounds have been reported in the literature, with Brahman and Brahman-cross cattle demonstrating increased susceptibility in some studies. Bos indicus genetics may affect drug metabolism or sensitivity, warranting additional caution and careful observation following treatment. European beef breeds and dairy breeds generally tolerate coumaphos well, but individual animals may occasionally demonstrate unexpected sensitivity. Animals showing adverse reactions should be treated promptly and not retreated with organophosphate products.

Production type considerations distinguish between beef and dairy cattle applications. Beef cattle can generally be treated with any approved coumaphos formulation with attention to slaughter withdrawal times. Dairy cattle face additional restrictions, with many products contraindicated in lactating animals and others requiring milk withdrawal periods. Dry dairy cows may be treated with some products as beef cattle, but careful attention to expected calving dates and resumption of milk sales is essential. Replacement dairy heifers should be treated only with products that will allow withdrawal periods to be completed well before freshening.

Age and weight considerations affect coumaphos use across cattle populations. Calves under three months of age may be more susceptible to toxicity and should be treated conservatively or excluded from treatment programs. Weight-based dosing for pour-on products requires accurate estimation, and using chute scales or weight tapes improves dosing precision. Very heavy animals may require multiple applications along the backline to deliver adequate doses of pour-on products. Aged or debilitated animals may have reduced metabolic capacity and should be monitored closely following treatment.

Same-class alternatives to coumaphos include other organophosphate ectoparasiticides that remain available for livestock use. Phosmet, tetrachlorvinphos, and dichlorvos represent organophosphates with varying spectrums of activity and application methods. These products share the cholinesterase inhibition mechanism and carry similar precautions regarding species restrictions, toxicity potential, and drug interactions. Rotation among organophosphates does not address resistance development, as cross-resistance within the class is common.

Different mechanism alternatives have become increasingly important as organophosphate resistance has developed in some parasite populations and as producers seek products with different safety profiles. Synthetic pyrethroids such as permethrin, cyfluthrin, and lambda-cyhalothrin offer effective ectoparasite control through sodium channel disruption rather than cholinesterase inhibition. Macrocyclic lactones including ivermectin, doramectin, eprinomectin, and moxidectin pour-ons provide systemic activity against grubs, lice, and mites through glutamate-gated chloride channel binding. Spinosad products offer another alternative mechanism for certain external parasite applications.

Combination products incorporating coumaphos with other active ingredients may be available for specific applications. Fly tags combining organophosphates with pyrethroids have been marketed to address resistance concerns through simultaneous exposure to multiple mechanisms. Dust and oiler formulations may combine coumaphos with synergists such as piperonyl butoxide to enhance efficacy. When considering combination products, producers must account for all active ingredients regarding withdrawal times, species restrictions, and potential interactions with other treatments the animals may receive.